Open the map

Neurocrine BiosciencesNBIX

Biotech & innovation · NASDAQ · USA

$141.25
Down 1.5% todayClose

Up 1.2% this year but −16.2% since June 26, behind the life science sector at +10.7%. Neurocrine Biosciences supplies 1 mapped company and buys from 1.

Market cap
$14.3B
This year
+1.2%
1 year
+4.7%
P/E
20.3
P/S
4.3
P/B
3.9

Price vs the life science sector

since Jun 26NBIXLife science sector, equal weight
Neurocrine Biosciences (NBIX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. NBIX: −16.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−20%−10%0%+10%Jun 26AugSepOct 8NBIX −16.2%Sector +10.7% Neurocrine Biosciences (NBIX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. NBIX: −16.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−20%−10%0%+10%Jun 26AugSepOct 8NBIX−16.2%Sector+10.7%

Supply chain

1 supplier · 1 customer
SUPPLIERS →→ CUSTOMERSIQVIA Holdings (IQV)IQVIQVIA Holdings+0.3%McKesson (MCK)MCKMcKesson+2.2%NBIXNeurocrine Bios…

Suppliers 1

Customers 1

Open the full chain →

About Neurocrine Biosciences

Ingrezza for tardive dyskinesia, plus a wider neurology and endocrine portfolio.

Theme exposure

Neuro biotechNeurologyEndocrinologyCNS therapy

Products

  • Ingrezza (tardive dyskinesia)
  • Endocrine portfolio
  • CNS pipeline

Competitors

Risks

  • Ingrezza concentration
  • Clinical pipeline risk

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Gilead SciencesGILD+0.2%Vertex PharmaceuticalsVRTX−0.5%ModernaMRNA+0.3%RegeneronREGN−0.3%BiogenBIIB−1.7%Alnylam PharmaceuticalsALNY+0.1%United TherapeuticsUTHR−2.2%

Compare NBIX

Side by side with the largest companies in the same segment.

NBIX vs AMGNNBIX vs GILDNBIX vs VRTXNBIX vs MRNANBIX vs REGNNBIX vs BIIB

See where Neurocrine Biosciences sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →